199 related articles for article (PubMed ID: 35737364)
1. Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group.
Raa DGT; van der Straten L; van Gelder M; Kersting S; Levin MD; Mous R; van der Straaten HM; Nijziel MR; van der Spek E; Posthuma EFM; Visser HPJ; van der Klift M; de Heer K; Bellido M; Doorduijn JK; Bruns AHW; Raijmakers RAP; Kater AP;
Leuk Lymphoma; 2022 Oct; 63(10):2276-2289. PubMed ID: 35737364
[TBL] [Abstract][Full Text] [Related]
2. Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia.
Dutch/Belgium HOVON CLL working group
Neth J Med; 2016 Feb; 74(2):68-74. PubMed ID: 26951351
[TBL] [Abstract][Full Text] [Related]
3. Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011.
Kater AP; Wittebol S; Chamuleau ME; van Gelder M; J van Oers MH; Hovon CLL Working Party
Neth J Med; 2011 Oct; 69(10):422-9. PubMed ID: 22058261
[TBL] [Abstract][Full Text] [Related]
4. Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands.
Kersting S; Neppelenbroek SIM; Visser HPJ; van Gelder M; Levin MD; Mous R; Posthuma W; van der Straaten HM; Kater AP
Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):52-57. PubMed ID: 29097160
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO).
Quinquenel A; Aurran-Schleinitz T; Clavert A; Cymbalista F; Dartigeas C; Davi F; de Guibert S; Delmer A; Dilhuydy MS; Feugier P; Fornecker LM; Ghez D; Guieze R; Laribi K; Leblond V; Leprêtre S; Letestu R; Lévy V; Nguyen-Khac F; Michallet AS; Tomowiak C; Tournilhac O; Ysebaert L; Troussard X
Hemasphere; 2020 Oct; 4(5):e473. PubMed ID: 33062946
[TBL] [Abstract][Full Text] [Related]
6. Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia.
Owen C; Gerrie AS; Banerji V; Assouline S; Chen C; Robinson KS; Lye E; Fraser G
Curr Oncol; 2018 Oct; 25(5):e461-e474. PubMed ID: 30464698
[TBL] [Abstract][Full Text] [Related]
7. Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update.
Owen C; Banerji V; Johnson N; Gerrie A; Aw A; Chen C; Robinson S
Leuk Res; 2023 Feb; 125():107016. PubMed ID: 36634577
[TBL] [Abstract][Full Text] [Related]
8. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Hallek M; Cheson BD; Catovsky D; Caligaris-Cappio F; Dighiero G; Döhner H; Hillmen P; Keating MJ; Montserrat E; Rai KR; Kipps TJ;
Blood; 2008 Jun; 111(12):5446-56. PubMed ID: 18216293
[TBL] [Abstract][Full Text] [Related]
10. Chronic Lymphocytic Leukemia: Current Concepts.
Yu EM; Kittai A; Tabbara IA
Anticancer Res; 2015 Oct; 35(10):5149-65. PubMed ID: 26408673
[TBL] [Abstract][Full Text] [Related]
11. Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia.
Owen C; Eisinga S; Banerji V; Johnson N; Gerrie AS; Aw A; Chen C; Robinson S
Leuk Res; 2023 Oct; 133():107372. PubMed ID: 37633157
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukaemia Australasian consensus practice statement.
Anderson MA; Bennett R; Badoux X; Best G; Chia N; Cochrane T; Cull G; Crassini K; Harrup R; Jackson S; Kuss B; Lasica M; Lew TE; Marlton P; Opat S; Palfreyman E; Polizzotto MN; Ratnasingam S; Seymour JF; Soosapilla A; Talaulikar D; Tam CS; Weinkove R; Wight J; Mulligan SP
Intern Med J; 2023 Sep; 53(9):1678-1691. PubMed ID: 37743239
[TBL] [Abstract][Full Text] [Related]
13. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.
Tees MT; Flinn IW
Expert Rev Hematol; 2017 Feb; 10(2):137-146. PubMed ID: 27936980
[TBL] [Abstract][Full Text] [Related]
15. Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies.
Rainone M; Siddiqi T
Curr Hematol Malig Rep; 2022 Feb; 17(1):39-45. PubMed ID: 35028825
[TBL] [Abstract][Full Text] [Related]
16. Emerging information on the use of rituximab in chronic lymphocytic leukemia.
Keating MJ; O'Brien S; Albitar M
Semin Oncol; 2002 Feb; 29(1 Suppl 2):70-4. PubMed ID: 11842391
[TBL] [Abstract][Full Text] [Related]
17. Minimizing and managing treatment-associated complications in patients with chronic lymphocytic leukemia.
Iskierka-Jażdżewska E; Robak T
Expert Rev Hematol; 2020 Jan; 13(1):39-53. PubMed ID: 31747803
[No Abstract] [Full Text] [Related]
18. Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017.
Jakšić B; Pejša V; Ostojić-Kolonić S; Kardum-Skelin I; Bašić-Kinda S; Coha B; Gverić-Krečak V; Vrhovac R; Jakšić O; Aurer I; Sinčić-Petričević J; Načinović-Duletić A; Nemet D
Acta Clin Croat; 2018 Mar; 57(1):190-215. PubMed ID: 30256032
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.
Cheson BD; Bennett JM; Rai KR; Grever MR; Kay NE; Schiffer CA; Oken MM; Keating MJ; Boldt DH; Kempin SJ
Am J Hematol; 1988 Nov; 29(3):152-63. PubMed ID: 3189311
[TBL] [Abstract][Full Text] [Related]
20. Lenalidomide in the treatment of chronic lymphocytic leukemia.
Itchaki G; Brown JR
Expert Opin Investig Drugs; 2017 May; 26(5):633-650. PubMed ID: 28388253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
